Kevin Tracey - 21 Jan 2026 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role: Director
Signature: /s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol: UTHR
Transactions as of: 21 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 23 Jan 2026, 16:32:15 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Tracey Kevin	Director	C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING	/s/ John S. Hess, Jr. under Power of Attorney	23 Jan 2026	0002107022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	UTHR	Restricted Stock Unit	Award	$0	+1,220		$0.000000	1,220	21 Jan 2026	Common Stock	1,220	$0.000000	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F2	In connection with Kevin Tracey's appointment to the Board of Directors on January 21, 2026, he was awarded restricted stock units in accordance with the Non-Employee Director Compensation Program. Each award becomes fully vested on the one-year anniversary of the grant date.
F3	Not applicable as restricted stock units do not have an expiration date.